The role of general practitioners in diagnosis of cutaneous melanoma: a population-based study in France
F. Grange
Service de Dermatologie, Hôpital Robert Debré, Université de Reims-Champagne-Ardenne, avenue du général Koenig, 51092 Reims Cedex, France
Search for more papers by this authorC. Barbe
Unité d’Aide Méthodologique, Hôpital Maison Blanche, Reims, France
Search for more papers by this authorL. Mas
Service de Dermatologie, Hôpital Robert Debré, Université de Reims-Champagne-Ardenne, avenue du général Koenig, 51092 Reims Cedex, France
Search for more papers by this authorF. Granel-Brocard
Service de Dermatologie, Hôpital Brabois, Vandoeuvre les Nancy, France
Search for more papers by this authorD. Lipsker
Clinique Dermatologique, Hôpital Civil, Strasbourg, France
Search for more papers by this authorF. Aubin
Service de Dermatologie, Hôpital Saint Jacques, Besançon, France
Search for more papers by this authorM. Velten
Registre des Cancers du Bas-Rhin and Réseau Français des Registres de Cancers FRANCIM, Strasbourg, France
Search for more papers by this authorS. Dalac
Service de Dermatologie, Hôpital du Bocage, Dijon, France
Search for more papers by this authorF. Truchetet
Service de Dermatologie, Hôpital Beauregard, Thionville, France
Search for more papers by this authorC. Michel
Service de Dermatologie, Hôpital du Moenschberg, Mulhouse, France
Search for more papers by this authorA. Mitschler
Service de Dermatologie, Hôpital Louis Pasteur, Colmar, France
Search for more papers by this authorG. Arnoult
Centre de Recherche et d’Investigation Clinique, Hôpital Maison Blanche, Reims, France
Search for more papers by this authorA. Buemi
Registre des Cancers du Haut-Rhin and Réseau Français des Registres de Cancers FRANCIM, Mulhouse, France
Search for more papers by this authorS. Dalle
Service de Dermatologie, Hôpital de l’Hôtel-Dieu, Lyon, France
Search for more papers by this authorP. Bernard
Service de Dermatologie, Hôpital Robert Debré, Université de Reims-Champagne-Ardenne, avenue du général Koenig, 51092 Reims Cedex, France
Search for more papers by this authorA.S. Woronoff
CHU de Besançon and Réseau Français des Registres de Cancers FRANCIM; Registre des Tumeurs du Doubs, Besançon, France
Search for more papers by this authorF. Arnold
Association Départementale des Professions de Santé pour le Dépistage des Cancers, Reims, France
Search for more papers by this authorF. Grange
Service de Dermatologie, Hôpital Robert Debré, Université de Reims-Champagne-Ardenne, avenue du général Koenig, 51092 Reims Cedex, France
Search for more papers by this authorC. Barbe
Unité d’Aide Méthodologique, Hôpital Maison Blanche, Reims, France
Search for more papers by this authorL. Mas
Service de Dermatologie, Hôpital Robert Debré, Université de Reims-Champagne-Ardenne, avenue du général Koenig, 51092 Reims Cedex, France
Search for more papers by this authorF. Granel-Brocard
Service de Dermatologie, Hôpital Brabois, Vandoeuvre les Nancy, France
Search for more papers by this authorD. Lipsker
Clinique Dermatologique, Hôpital Civil, Strasbourg, France
Search for more papers by this authorF. Aubin
Service de Dermatologie, Hôpital Saint Jacques, Besançon, France
Search for more papers by this authorM. Velten
Registre des Cancers du Bas-Rhin and Réseau Français des Registres de Cancers FRANCIM, Strasbourg, France
Search for more papers by this authorS. Dalac
Service de Dermatologie, Hôpital du Bocage, Dijon, France
Search for more papers by this authorF. Truchetet
Service de Dermatologie, Hôpital Beauregard, Thionville, France
Search for more papers by this authorC. Michel
Service de Dermatologie, Hôpital du Moenschberg, Mulhouse, France
Search for more papers by this authorA. Mitschler
Service de Dermatologie, Hôpital Louis Pasteur, Colmar, France
Search for more papers by this authorG. Arnoult
Centre de Recherche et d’Investigation Clinique, Hôpital Maison Blanche, Reims, France
Search for more papers by this authorA. Buemi
Registre des Cancers du Haut-Rhin and Réseau Français des Registres de Cancers FRANCIM, Mulhouse, France
Search for more papers by this authorS. Dalle
Service de Dermatologie, Hôpital de l’Hôtel-Dieu, Lyon, France
Search for more papers by this authorP. Bernard
Service de Dermatologie, Hôpital Robert Debré, Université de Reims-Champagne-Ardenne, avenue du général Koenig, 51092 Reims Cedex, France
Search for more papers by this authorA.S. Woronoff
CHU de Besançon and Réseau Français des Registres de Cancers FRANCIM; Registre des Tumeurs du Doubs, Besançon, France
Search for more papers by this authorF. Arnold
Association Départementale des Professions de Santé pour le Dépistage des Cancers, Reims, France
Search for more papers by this authorFunding sources: This study was supported by a grant from the Ligue Contre le Cancer.
Conflicts of interest: None declared.
Summary
Background Little data are available concerning the role of general practitioners (GPs) in the diagnosis of melanoma.
Objectives To evaluate the actual role of GPs in a population-based study covering five regions of France and 8·2 million inhabitants.
Materials and methods A survey of cancer registries and pathology laboratories, and questionnaires to practitioners were used to identify incident melanomas in 2008, and evaluate characteristics of patients (age, sex, area of residence, social isolation), tumours (Breslow, ulceration, location, histological type), and GPs (training, conditions of practice), and their influence on patterns of diagnosis and Breslow thickness.
Results Among 898 melanomas, 376 (42%) were first diagnosed in a general practice setting (GP group). Breslow thickness was much higher in the GP group than in other melanomas (median: 0·95 vs. 0·61 mm, P < 0·0001). Multivariate analysis identified an older age, lower limb location, nodular subtype and Breslow thickness as factors associated with the GP group. Within this group, 52·5% of melanomas were detected by patients (median Breslow thickness: 1·30 mm) and 47·5% by GPs (median Breslow thickness: 0·80 mm, P = 0·0009), including 8% during a systematic full-body skin examination. Previous GP training on melanoma was associated with active detection by GPs. Male sex and social isolation of patients were associated with thicker melanomas, whereas active detection by GPs was associated with thinner CMs.
Conclusions GPs play a key role in melanoma diagnosis in France, but still frequently detect thick tumours. Increasing awareness and training of GPs and focusing attention on male and/or socially isolated patients should help to improve early detection of melanoma.
References
- 1 MacKie RM, Hole D, Hunter JA et al. Cutaneous malignant melanoma in Scotland: incidence, survival, and mortality, 1979–94. The Scottish Melanoma Group. BMJ 1997; 315: 1117–21.
- 2 Grange F. [Epidemiology of cutaneous melanoma: descriptive data in France and Europe]. Ann Dermatol Venereol 2005; 132: 975–82. (in French)
- 3 Ferlay J, Parkin DM, Steliarova-Foucher E. Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer 2010; 46: 765–81.
- 4 Garbe C, Leiter U. Melanoma epidemiology and trends. Clin Dermatol 2009; 27: 3–9.
- 5 Geller AC, O’Riordan DL, Oliveria SA et al. Overcoming obstacles to skin cancer examinations and prevention counseling for high-risk patients: results of a national survey of primary care physicians. J Am Board Fam Pract 2004; 17: 416–23.
- 6 Richard MA, Grob JJ, Avril MF et al. Delays in diagnosis and melanoma prognosis (II): the role of doctors. Int J Cancer 2000; 89: 280–5.
- 7 Oliveria SA, Heneghan MK, Cushman LF et al. Skin cancer screening by dermatologists, family practitioners, and internists: barriers and facilitating factors. Arch Dermatol 2011; 147: 39–44.
- 8 Grange F, Hédelin G, Halna J-M et al. [Assessment of a general practitioner training campaign for early detection of cutaneous melanoma in the Haut-Rhin department of France]. Ann Dermatol Venereol 2005; 132: 956–61, (in French).
- 9 Geller AC, Swetter SM, Oliveria S et al. Reducing mortality in individuals at high risk for advanced melanoma through education and screening. J Am Acad Dermatol 2011; 5 (Suppl. 1): S87–94.
- 10 Khorshid SM, Pinney E, Bishop JA. Melanoma excision by general practitioners in north-east Thames region, England. Br J Dermatol 1998; 138: 412–17.
- 11
Brady MS,
Oliveria SA,
Christos PJ
et al.
Patterns of detection in patients with cutaneous melanoma.
Cancer
2000; 89: 342–7.
10.1002/1097-0142(20000715)89:2<342::AID-CNCR19>3.0.CO;2-P CAS PubMed Web of Science® Google Scholar
- 12 Baade PD, Youl PH, English DR et al. Clinical pathways to diagnose melanoma: a population-based study. Melanoma Res 2007; 17: 243–9.
- 13 Pennie ML, Soon SL, Risser JB et al. Melanoma outcomes for Medicare patients: association of stage and survival with detection by a dermatologist vs a nondermatologist. Arch Dermatol 2007; 143: 488–94.
- 14 Barbe C, Hibon E, Vitry F et al. Clinical and pathological characteristics of melanoma: a population-based study in a French regional population. J Eur Acad Dermatol Venereol 2012; 26: 159–64.
- 15 Durbec F, Vitry F, Granel-Brocard F et al. The role of circumstances of diagnosis and access to dermatological care in early diagnosis of cutaneous melanoma: a population-based study in France. Arch Dermatol 2010; 146: 240–6.
- 16 Terushkin V, Halpern AC. Melanoma early detection. Hematol Oncol Clin North Am 2009; 23: 481–500, viii.
- 17 Carli P, De Giorgi V, Palli D et al. Patterns of detection of superficial spreading and nodular-type melanoma: a multicenter Italian study. Dermatol Surg 2004; 30: 1371–5; discussion 1375–6.
- 18 Baumert J, Plewig G, Volkenandt M, Schmid-Wendtner M-H. Factors associated with a high tumour thickness in patients with melanoma. Br J Dermatol 2007; 156: 938–44.
- 19 Nagore E, Oliver V, Botella-Estrada R et al. Clinicopathological analysis of 1571 cutaneous malignant melanomas in Valencia, Spain: factors related to tumour thickness. Acta Derm Venereol 2006; 86: 50–6.
- 20 Richard MA, Grob JJ, Avril MF et al. Delays in diagnosis and melanoma prognosis (I): the role of patients. Int J Cancer 2000; 89: 271–9.
- 21 Geller AC, Elwood M, Swetter SM et al. Factors related to the presentation of thin and thick nodular melanoma from a population-based cancer registry in Queensland Australia. Cancer 2009; 115: 1318–27.
- 22 Chamberlain AJ, Fritschi L, Giles GG et al. Nodular type and older age as the most significant associations of thick melanoma in Victoria, Australia. Arch Dermatol 2002; 138: 609–14.
- 23 Lipsker D, Engel F, Cribier B et al. Trends in melanoma epidemiology suggest three different types of melanoma. Br J Dermatol 2007; 157: 338–43.
- 24 Durbec F, Martin L, Derancourt C, Grange F. Melanoma of the hand and foot: epidemiological, prognostic and genetic features. A systematic review. Br J Dermatol 2012; 166: 727–39.
- 25 Geller AC, Johnson TM, Miller DR et al. Factors associated with physician discovery of early melanoma in middle-aged and older men. Arch Dermatol 2009; 145: 409–14.
- 26 McPherson M, Elwood M, English DR et al. Presentation and detection of invasive melanoma in a high-risk population. J Am Acad Dermatol 2006; 54: 783–92.
- 27 Youl PH, Baade PD, Janda M et al. Diagnosing skin cancer in primary care: how do mainstream general practitioners compare with primary care skin cancer clinic doctors? Med J Aust 2007; 187: 215–20.
- 28 Van Durme DJ, Ferrante JM, Pal N et al. Demographic predictors of melanoma stage at diagnosis. Arch Fam Med 2000; 9: 606–11.
- 29 Grange F, Vitry F, Granel-Brocard F et al. Variations in management of stage I to stage III cutaneous melanoma: a population-based study of clinical practices in France. Arch Dermatol 2008; 144: 629–36.